1. Bedaquiline: 10 years later, the drug susceptibility testing protocol is still pending
2. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
3. Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
4. World Health Organization. The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance. Geneva, World Health Organization, 2013. Available from: http://apps.who.int/iris/bitstream/10665/84879/1/9789241505482_eng.pdf
5. World Health Organization. Policy Implementation Package For New TB Drug Introduction. Geneva, World Health Organization. 2014. Available from: http://www.who.int/tb/PIPnewTBdrugs.pdf